Inventor · disambiguated record
James Empfield
Also filed as: EMPFIELD JAMES · EMPFIELD JAMES R · EMPFIELD JAMES ROY
28 granted patents·11 pending applications·165 citations·filing 1993–2020
96Inventor score
Files withASTRAZENECA AB18ZENECA LTD11XENON PHARMACEUTICALS INC5VAN WAGENEN BRADFORD2ALBERT JEFFREY SCOTT1
Top patents by PatentIndex Score
39 records- 0195US11299490B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·3 cites·24 claims
- 0292US10246453B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Granted Apr 2, 2019·10 cites·68 claims
- 0391US10662184B2Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2019·Granted May 26, 2020·4 cites·3 claims
- 0490US11174268B2Benzenesulfonamide compouds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2020·Granted Nov 16, 2021·2 cites·25 claims
- 0588US7799792B2Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841ASTRAZENECA AB·Filed 2008·Granted Sep 21, 2010·11 cites·14 claims
- 0686US7868008B2Substituted isoindolones and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2006·Granted Jan 11, 2011·11 cites·4 claims
- 0782US7807706B2Metabotropic glutamate-receptor-potentiating isoindolonesASTRAZENECA AB·Filed 2006·Granted Oct 5, 2010·6 cites·9 claims
- 0882US7790760B2Metabotropic glutamate receptor isoxazole ligands and their use as potentiators 286ASTRAZENECA AB·Filed 2009·Granted Sep 7, 2010·4 cites·7 claims
- 0982US5744471APyridazion quinoline compoundsZENECA LTD·Filed 1994·Granted Apr 28, 1998·36 cites·6 claims
- 1081US8377940B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·4 cites·13 claims
- 1181US7968570B2Isoindolone compounds and their use as metabotropic glutamate receptor potentiatorsASTRAZENECA AB·Filed 2005·Granted Jun 28, 2011·6 cites·4 claims
- 1277US7781434B2Metabotropic glutamate receptor isoxazole ligands and their use as potentiators—286ASTRAZENECA AB·Filed 2009·Granted Aug 24, 2010·2 cites·7 claims
- 1376US7205314B2Compounds for the treatment of dementia related diseasesASTRAZENECA AB·Filed 2002·Granted Apr 17, 2007·12 cites·8 claims
- 1475US7888353B2Metabotropic glutamate receptor isoxazole ligands and their use as potentiatorsASTRAZENECA AB·Filed 2010·Granted Feb 15, 2011·2 cites·4 claims
- 1574US5482969ACertain N(4-benzoyl-2-phenyl)-3- trifluoro-2-hydroxy-propanamide derivativesZENECA LTD·Filed 1994·Granted Jan 9, 1996·13 cites·8 claims
- 1667US5510386AAminosulfonylphenyl compounds for treating urinary incontinenceZENECA LTD·Filed 1994·Granted Apr 23, 1996·18 cites·9 claims
- 1762US8377939B2Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842ASTRAZENECA AB·Filed 2008·Granted Feb 19, 2013·0 cites·4 claims
- 1861US7384954B24-substituted imidazolesASTRAZENECA AB·Filed 2004·Granted Jun 10, 2008·1 cites·10 claims
- 1957US2010280082A1Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as PotentiatorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2050US5837705AAlpha-substituted pyridazino quinoline compoundsZENECA LTD·Filed 1996·Granted Nov 17, 1998·8 cites·3 claims
- 2148US8148372B2Metabotropic glutamate receptor isoxazole ligands and their use as potentiators—286CACCIOLA JOSEPH·Filed 2010·Granted Apr 3, 2012·0 cites·7 claims
- 2248US5693639ATherapeutic heterocyclyl amionosulfonyl phenyl compoundsZENECA LTD·Filed 1996·Granted Dec 2, 1997·3 cites·9 claims
- 2347US2018162868A1Benzenesulfonamide compounds and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2447US2008188518A15-Substituted ImidazolesASTRAZENECA AB·Filed 2004·Application pending·0 cites
- 2545US2009149505A1Metabotropic Glutamate Receptor-Potentiating IsoindolonesASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 2644US2008318985A1Novel 2-Aminopyrimidinone Or 2-Aminopyridinone Derivatives and Their UseASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2743US5900432ATherapeutic N-(4-benzoyl-2-methyl-phenyl)-3,3,3-trifluoro-2-hydroxy-2-methyl-propanamidesZENECA LTD·Filed 1995·Granted May 4, 1999·2 cites·7 claims
- 2843US2011166155A1Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor PotentiatorsVAN WAGENEN BRADFORD·Filed 2011·Application pending·0 cites
- 2942US2009221579A1Substituted Amino-Compounds and Uses ThereofALBERT JEFFREY SCOTT·Filed 2005·Application pending·0 cites
- 3041US2009062282A1Substituted Amino-Pyrimidones and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 3140US2008306087A1Therapeutic AgentsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3240US2008214570A1Therapeutic AgentsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 3339US5411973ATherapeutic alcoholsZENECA LTD·Filed 1993·Granted May 2, 1995·3 cites·7 claims
- 3438US6214826B1Pyridazino quinoline compoundsZENECA LTD·Filed 1999·Granted Apr 10, 2001·1 cites·8 claims
- 3537US8153638B2Metabotropic glutamate-receptor-potentiating isoindolonesVAN WAGENEN BRADFORD·Filed 2010·Granted Apr 10, 2012·0 cites·3 claims
- 3637US6103721AHeteroaryl-substituted pyridazino quinoline compoundsZENECA LTD·Filed 1999·Granted Aug 15, 2000·1 cites·9 claims
- 3737US2002137750A1Amidine derivatives which are inhibitors of nitric oxide synthaseFiled 2000·Application pending·0 cites
- 3836US6232313B1Pyridazino quinoline compoundsZENECA LTD·Filed 1998·Granted May 15, 2001·1 cites·10 claims
- 3934US6737424B2Alpha-substituted pyridazino quinoline compoundsZENECA LTD·Filed 1998·Granted May 18, 2004·1 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →